BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21050736)

  • 1. To B or not to B--pathogenic and regulatory B cells in autoimmune diabetes.
    Wong FS; Hu C; Xiang Y; Wen L
    Curr Opin Immunol; 2010 Dec; 22(6):723-31. PubMed ID: 21050736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen processing by autoreactive B cells promotes determinant spreading.
    Dai YD; Carayanniotis G; Sercarz E
    Cell Mol Immunol; 2005 Jun; 2(3):169-75. PubMed ID: 16212883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of pathogenic B-cell clones in antibody mediated autoimmune disorders.
    Wang J; Zhu X
    J Dermatol Sci; 2004 Dec; 36(3):141-8. PubMed ID: 15541635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cells and autoimmune liver diseases.
    Moritoki Y; Lian ZX; Ohsugi Y; Ueno Y; Gershwin ME
    Autoimmun Rev; 2006 Aug; 5(7):449-57. PubMed ID: 16920571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.
    Silveira PA; Johnson E; Chapman HD; Bui T; Tisch RM; Serreze DV
    Eur J Immunol; 2002 Dec; 32(12):3657-66. PubMed ID: 12516557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow?
    Roep BO
    Springer Semin Immunopathol; 2002 Dec; 24(3):261-71. PubMed ID: 12503054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
    Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
    J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell-directed therapies in type 1 diabetes.
    Mariño E; Silveira PA; Stolp J; Grey ST
    Trends Immunol; 2011 Jun; 32(6):287-94. PubMed ID: 21531625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.
    Silveira PA; Grey ST
    Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases.
    Alyanakian MA; You S; Damotte D; Gouarin C; Esling A; Garcia C; Havouis S; Chatenoud L; Bach JF
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15806-11. PubMed ID: 14673094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of xenotransplantation of pancreatic islet cells on the immune status of patients with diabetes mellitus].
    Morozov IuI; Kirdeĭ EG; Kim AIu
    Klin Med (Mosk); 1995; 73(2):32-4. PubMed ID: 7609413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus].
    Shishko PI
    Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenic functions of B cells in autoimmune diseases: IFN-γ production joins the criminal gang.
    Fillatreau S
    Eur J Immunol; 2015 Apr; 45(4):966-70. PubMed ID: 25727209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
    Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
    Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes.
    Bendelac A; Boitard C; Bedossa P; Bazin H; Bach JF; Carnaud C
    J Immunol; 1988 Oct; 141(8):2625-8. PubMed ID: 3262666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New findings on the pathogenesis of diabetes mellitus].
    Keller U
    Schweiz Med Wochenschr; 1986 Jan; 116(3):66-71. PubMed ID: 3511524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T-cells in type 1 diabetes.
    Juedes AE; von Herrath MG
    Diabetes Metab Res Rev; 2004; 20(6):446-51. PubMed ID: 15386802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory B cells in autoimmune diseases: how do they work?
    Lemoine S; Morva A; Youinou P; Jamin C
    Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.